Physician profile
Hannah Solon
NPI 1548080310
$1,144.80
in general payments reported to CMS, 2019-2025
14 companies · $1,145 in 2025
The $1,145 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996 · Education: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.82 |
| Education | $148.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $232.11 | 2025 | Nucala, Trelegy Ellipta |
| Astellas Pharma US INC | $206.00 | 2025 | Cresemba |
| Merck Sharp & Dohme LLC | $128.22 | 2025 | Winrevair, Keytruda |
| Amgen INC. | $124.73 | 2025 | Tavneos |
| Astrazeneca Pharmaceuticals LP | $105.02 | 2025 | Fasenra, Tezspire |
| United Therapeutics Corporation | $90.01 | 2025 | Tyvaso, Remodulin |
| Actelion Pharmaceuticals US, INC. | $79.62 | 2025 | Uptravi, Opsynvi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.91 | 2025 | Jardiance, Jascayd |
| Pulmonx Corporation | $22.91 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Takeda Pharmaceuticals U.S.A., INC. | $19.41 | 2025 | Livtencity |
| Viatris Specialty LLC | $19.06 | 2025 | Yupelri |
| Invivyd INC | $17.67 | 2025 | Pemgarda |
| Bayer Healthcare Pharmaceuticals INC. | $16.24 | 2025 | |
| Alnylam Pharmaceuticals INC. | $13.89 | 2025 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Solon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.